FIELD: medicine.
SUBSTANCE: claimed is method of diagnosing phenotype of multiple medication resistance. Unicellular suspensions are prepared from tumour tissue and comparison cultures and fixed, after which incubation with primary and secondary antibodies and double washing are carried out. D values of statistical test of Kholmogorov-Smirnov are calculated and on the basis of obtained data determined is coefficient of level of expression of multiple medication resistance markers, showing phenotype expression. Coefficient of expression level makes it possible to point out three degrees of its expression: low, medium and high. On the basis of coefficient it is possible to determine tumour sensitivity to chemical preparations.
EFFECT: method makes it possible to increase accuracy of determining multiple medication resistance markers and carry out analysis in short terms.
2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF FLUORESCENCE IMMUNOASSAY OF OESTROGEN β RECEPTORS IN HUMAN SOLID TUMOURS | 2010 |
|
RU2429481C1 |
| METHOD FOR IMMUNOFLUORESCENCE ASSAY OF EXCISION REPAIR PROTEIN ERCC1 IN HUMAN SOLID TUMOURS | 2014 |
|
RU2563116C1 |
| METHOD FOR DETERMINING INDIVIDUAL SOLID HUMAN TUMOR SENSITIVITY TO CHEMOTHERAPY | 2005 |
|
RU2315997C2 |
| METHOD FOR MOLECULAR QUANTITATIVE DETECTION OF LOCAL PREVALENCE OF NON-SMALL CELL LUNG CANCER BY DOUBLE IMMUNOFLUORESCENT STAINING OF NORMAL AND TUMOUR TISSUE | 2020 |
|
RU2732973C1 |
| METHOD FOR QUANTITATIVE ASSESSMENT OF CELL FRACTION IN EPITHELIAL-MESENCHYMAL PASSAGE IN ASCITIC FLUID AND SOLID TUMORS OF OVARIAN CANCER | 2018 |
|
RU2704814C1 |
| METHOD FOR ESTIMATION OF TOTAL INDICATOR OF ANEUPLOIDY AND PROLIFERATIVE ACTIVITY OF TUMOUR CELLS OF NON-SMALL-CELL LUNG CANCER AND OVARIAN CANCER USING SPECIFIC DNA DYE DRAQ7 OF NEW GENERATION | 2016 |
|
RU2639251C1 |
| MONOMOLECULAR CHIMERIC T-CELL RECEPTOR TO CANCER ANTIGEN CA125 | 2018 |
|
RU2747095C2 |
| DIAGNOSTIC TECHNIQUE FOR AUTOIMMUNE THYROIDITIS | 2023 |
|
RU2826338C1 |
| ANTI-TUMOUR PREPARATION | 2011 |
|
RU2451509C1 |
| ANTITUMOR TARGET CELL PRODUCT, METHOD FOR ITS PRODUCTION AND ITS APPLICATION | 2018 |
|
RU2757812C2 |
